Profitability Improvement
TECH achieved a 95% increase in operating income and a 126% rise in net income, primarily due to a 27.7% reduction in SG&A expenses.
BIO-TECHNE Corp is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: TECH's Q3 FY2026 results show a significant improvement in profitability despite a slight decline in revenue, driven by cost reductions and increased operational efficiency.
Drawn from management commentary in the Q1 2026 10-Q:
TECH achieved a 95% increase in operating income and a 126% rise in net income, primarily due to a 27.7% reduction in SG&A expenses.
Revenue decreased by 1.5% year-over-year, indicating challenges in maintaining sales growth.
Cash and equivalents increased by 49.2%, enhancing liquidity and financial flexibility.
Revenue
$311.42M
-1.51% YoY
EPS (Basic)
$0.33
++135.71% YoY
Gross Margin
66.9%
-0.97% YoY
Operating Income
$75.5M
++95.04% YoY
Add TECH to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.